Novo Nordisk said on Monday it has begun selling its popular weight-loss drug Wegovy for $349 a month to cash payers, months ...

Novo Nordisk has more than enough of its Wegovy weight-loss pills to support an aggressive product launch, CEO Mike Doustdar ...

Wegovy-maker Novo Nordisk's CEO said on Monday a deal with the White House to slash prices on its popular weight‑loss drugs ...

Trump hints at Affordable Care Act replacement as Dr. Oz outlines healthcare reform plans emphasizing consumer choice and ...

Under its terms, those products will be sold by their developers through a planned national online drug platform called TrumpRx at a steep discount to certain current rates (under agreements set with ...

This prompted an unusual and bitter bidding war, where Doustdar goaded Pfizer to raise its bid during a press conference in the Oval Office. In the end, Pfizer won by matching Novo’s $10bn offer, as ...

Investing.com -- Novo Nordisk ’s CEO Mike Doustdar said Monday that the company’s agreement with the White House to reduce prices on its popular weight-loss drugs is designed to expand access through ...

US accounts for 72.7% of the MSCI World Index, compared with just 2.6% for Europe’s biggest stock market, France ...

Trump deals with Eli Lilly and Novo Nordisk increase access to obesity drugs, providing a safe, convenient way to slim down ...

Judge says he’ll approve opioid settlement with OxyContin maker Purdue and Sackler family; Merck buys Cidara; ByHeart’s ...

President Trump has successfully negotiated a groundbreaking deal to include obesity drugs under Medicare coverage, marking a ...

In this video, Paul Kwo, MD, highlights results from a meta-analysis that compared cardiovascular and liver-related outcomes among non-lean and lean individuals with metabolic dysfunction-associated ...